BVS Bioventus Forecast, Technical & Fundamental Analysis
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions... Show more
BVS is expected to report earnings to rise 12.27% to 16 cents per share on November 10
Q3'26
Est.
$0.17
Q1'26
Beat
by $0.05
Q4'25
Beat
by $0.04
Q3'25
Beat
by $0.04
Q2'25
Est.
$0.21
The last earnings report on May 06 showed earnings per share of 15 cents, beating the estimate of 10 cents. With 257.25K shares outstanding, the current market capitalization sits at 1.17B.
A.I.dvisor indicates that over the last year, BVS has been loosely correlated with ENOV. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BVS jumps, then ENOV could also see price increases.
Aroon Indicator for BVS shows an upward move is likely
BVS's Aroon Indicator triggered a bullish signal on August 14, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 195 similar instances where the Aroon Indicator showed a similar pattern. In of the 195 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on July 27, 2026. You may want to consider a long position or call options on BVS as a result. In of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where BVS advanced for three days, in of 278 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The 10-day RSI Indicator for BVS moved out of overbought territory on August 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 56 cases where BVS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for BVS turned negative on August 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BVS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
BVS broke above its upper Bollinger Band on August 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BVS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.115) is normal, around the industry mean (10.966). P/E Ratio (17.808) is within average values for comparable stocks, (70.481). Projected Growth (PEG Ratio) (1.769) is also within normal values, averaging (3.967). BVS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.017). P/S Ratio (1.665) is also within normal values, averaging (32.687).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BVS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
